alzheimer-s-disease

Documents about alzheimer-s-disease

• Designing a communication strategy to promote Alzheimer's disease prevention: The CULTIVAMENTE campaign.#145792NCBI PubMed Central
• Tau pathological activity in plasma before the onset of symptomatic Alzheimer s disease#151581bioRxiv / medRxiv
• Predicting progression of Alzheimer’s disease using blood-based multi-omics data.#170764NCBI PubMed Central
• Effect of Insulin Sensitizer Metformin on AD Biomarkers#208393ClinicalTrials.gov
• Artificial intelligence for detection and staging of Alzheimer's disease using retinal images.#218780NCBI PubMed Central
• Predicting categorical and continuous Alzheimer's disease outcomes from a single MRI scan.#218805NCBI PubMed Central
• Influence of an AQP4 haplotype and sleep duration on early Alzheimer's disease.#265292NCBI PubMed Central
• Tunable acoustic rotation for deep biophysical phenotyping of preclinical Alzheimer's disease.#266942NCBI PubMed Central
• Smartphone-based detection of subtle memory decline in prodromal Alzheimer's disease#273297Europe PMC
• Mechanisms of increased Alzheimer's disease pathology with R47H and R62H TREM2 variants.#284882NCBI PubMed Central
• Direct RNA Sequencing reveals epitranscriptomic regulation of brain cells and Alzheimer's Disease pathology#287239bioRxiv / medRxiv
• Adaptive neighborhood aggregation graph neural network for early diagnosis of Alzheimer's disease.#297188NCBI PubMed Central
• Redirecting Alzheimer's disease therapeutics: Multitarget drugs and complementary non-pharmacological strategies.#312379NCBI PubMed Central
• The Utility of Speech and Language Analytics for Screening Alzheimer's Disease.#315801NCBI PubMed Central
• Development of a serum-based microRNA panel for Alzheimer's disease diagnosis.#334740NCBI PubMed Central
• Unveiling the procoagulant state in Alzheimer's disease: A novel PET imaging strategy.#340273NCBI PubMed Central
• Lymphoid-like Suppressive Microglia in Alzheimer's Disease: A New Neuroimmune Regulatory Axis?#367991NCBI PubMed Central
• Alzheimer's disease: A comprehensive review of epidemiology, pathophysiology, diagnosis, and treatment.#371445NCBI PubMed Central
• Abnormal hippocampo-cortical theta-gamma phase-amplitude coupling in Alzheimer’s disease#422492Europe PMC
• Generalized Multilevel Multisource Functional Regression With an Application to Alzheimer's Disease.#431006NCBI PubMed Central
• Advancements in non-pharmaceutical interventions for Alzheimer's disease management: an update review.#433762NCBI PubMed Central
• Thalamic volume alterations mediate glymphatic function and cognitive dysfunction in Alzheimer's disease.#436861NCBI PubMed Central
• Ferroptosis-related biomarkers for diagnosis and mechanistic insights into Alzheimer's disease.#437026NCBI PubMed Central
• Plasma P-tau217 for detecting amyloid clearance after donanemab in Alzheimer's disease.#438938NCBI PubMed Central
• Clinical-biological Alzheimer's disease stage concordance: insights from cohorts and autopsy data.#442868NCBI PubMed Central
• Mental health and gut-brain crosstalk: implications for depression and Alzheimer's disease.#455133NCBI PubMed Central
• What Do Persistent Misclassifications Tell Us About Alzheimer's Disease Detection using Structural MRI?#463564bioRxiv / medRxiv
• Mapping Amyloid-PET Uptake in the White Matter in Alzheimer’s Disease#475680Europe PMC
• Functional assessment improves discrimination of clinical and biomarker-defined Alzheimer’s disease#475740Europe PMC
• Genetic ablation of neuronal mitochondrial calcium uptake impedes Alzheimer's disease progression#478595Europe PMC
• Beyond the Cochrane review: Re-evaluating anti-amyloid therapy in Alzheimer's disease.#479178NCBI PubMed Central
• Single-cell multiomics connects 3D genome and transcriptome alterations in Alzheimer's disease.#480783NCBI PubMed Central
• Indices of Arterial Stiffness and the Alzheimer s Disease Biomarker, p-tau217, in Non-Demented Midlife Women#357806ScholarBank@NUS
• A comprehensive assessment of cholinesterase inhibitors for the treatment of Alzheimer’s disease based on drug selection recommendations for Chinese Medical Institutions#436111Figshare
• Life satisfaction and risk of dementia over 18 years: an analysis of the National Alzheimer's Coordinating Center dataset#257567HAL (France)
• Susceptible genes and disease mechanisms identified in frontotemporal dementia and frontotemporal dementia with Amyotrophic Lateral Sclerosis by DNA-methylation and GWAS#620182eScholarship
• Associations of lifestyle factors and genetic risk with risk and rate advancement periods of dementia#397180OSF
• TREM2 as a central immunometabolic hub in Alzheimer's disease: linking microglial states, lipid stress, and disease-stage-specific intervention.#457307NCBI PubMed Central
• Antemortem α-Synuclein levels from neuron-derived extracellular vesicles identify Lewy Body pathology in Parkinson's Disease and Alzheimer Disease#640151bioRxiv / medRxiv
• Label-free paper-based electrochemical aptasensor with tunable selectivity for assessing neurotransmitter imbalance in Alzheimer's disease.#165491NCBI PubMed Central
• Considerations for the selection and phenotyping of mouse models for the study of Alzheimer's disease.#305126NCBI PubMed Central
• Neuroticism is linked to cognitive decline and increased risk of Alzheimer's disease through dysregulation of excitatory neurons#407663bioRxiv / medRxiv
• Resting-State EEG Alpha Rhythms Are Related to CSF Tau Biomarkers in Prodromal Alzheimer's Disease#185646IRIS
• Theoretical impact of a mobile team dedicated to patients with Alzheimer’s disease and related dementias on medication exposure in community-dwelling older patients (MEMORIAS study)#374428HAL (France)
• PREreview of "Astrocyte-neuron mitochondrial transfer via mitoEVs supports neuronal energy metabolism and is impaired in early Alzheimer's disease"#432352Zenodo (CERN)
• Predicting Progression from Mild Cognitive Impairment to Alzheimer’s Disease using Blood-Based Biomarkers and Amyloid-Beta PET: A Survival Analysis Approach#235048Harvard DASH
• Promotores program to increase Hispanic/Latino(a) participation in Alzheimer's disease research.#4116NCBI PubMed Central
• Olfactory decline tracks central-to-peripheral spread of tau pathology in Alzheimer's disease.#13431NCBI PubMed Central
• Review of Artificial Intelligence for Clinical Use in Alzheimer's Disease and Related Dementias.#13604NCBI PubMed Central
• Dynamic Alterations of Functional Systems in Alzheimer's Disease: A Co-Activation Pattern Analysis.#14856NCBI PubMed Central